Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Yano

Showing results (471-480 of 958) with videos related to

Pageof 96
Sort By:
The Journal of Biological Chemistry|February 15, 1991
Specific localization of phosphointermediate filament protein in the constricted area of dividing cellsK Nishizawa, T Yano, M Shibata, et al.
Cancer Research|March 1, 1991
Cytolytic potential of peripheral blood T-lymphocytes following adoptive immunotherapy with lymphokine-activated killer cells and low-dose interleukin 2I Yoshino, T Yano, M Murata, et al.
Rheumatology International|November 28, 2008
Effects of bosentan on the skin lesions: an observational study from a single center in JapanMasanori Funauchi, K Kishimoto, H Shimazu, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 28, 2006
Immediate maxillary reconstruction after malignant tumor extirpationS Sarukawa, M Sakuraba, T Asano, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|February 1, 1990
[A case of Mycoplasma pneumoniae infection followed by Staphylococcus aureus bacteremia]T Yano, S Kawaguchi, T Higashi, et al.
Cellular Immunology|September 1, 1989
Phenotypic characterization of lymphokine-activated killer cells from human lymph node lymphocytesT Yano, M Murata, T Ishida, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1987
[Serum NSE (neuron-specific enolase) levels in small cell lung cancer, with special reference to the measurement of serial serum NSE levels]S Kawachi, Z Shimabukuro, A Aoyama, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1988
[Accumulating patterns of lipiodol and therapeutic effect of combination therapy with ADMOS and CDDP two-route infusion in hepatocellular carcinoma]Y Hiraki, H Kobayashi, Y Itoh, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|August 1, 1995
[Eight cases of infection caused by the Streptococcus milleri group--significance of serum antibody titer and a comparative investigation of the backgrounds and factors of infections caused by Streptococcus milleri and Streptococcus pneumoniae]M Kimura, T Matsushima, Y Tano, et al.
Biochemical and Biophysical Research Communications|May 20, 1998
A putative tumor suppressor, TSG101, acts as a transcriptional suppressor through its coiled-coil domainM Watanabe, Y Yanagi, Y Masuhiro, et al.
Pageof 96

Showing results (471-480 of 958) with videos related to

Sort By:
Pageof 96
The Journal of Biological Chemistry|February 15, 1991
Specific localization of phosphointermediate filament protein in the constricted area of dividing cellsK Nishizawa, T Yano, M Shibata, et al.
Cancer Research|March 1, 1991
Cytolytic potential of peripheral blood T-lymphocytes following adoptive immunotherapy with lymphokine-activated killer cells and low-dose interleukin 2I Yoshino, T Yano, M Murata, et al.
Rheumatology International|November 28, 2008
Effects of bosentan on the skin lesions: an observational study from a single center in JapanMasanori Funauchi, K Kishimoto, H Shimazu, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 28, 2006
Immediate maxillary reconstruction after malignant tumor extirpationS Sarukawa, M Sakuraba, T Asano, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|February 1, 1990
[A case of Mycoplasma pneumoniae infection followed by Staphylococcus aureus bacteremia]T Yano, S Kawaguchi, T Higashi, et al.
Cellular Immunology|September 1, 1989
Phenotypic characterization of lymphokine-activated killer cells from human lymph node lymphocytesT Yano, M Murata, T Ishida, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1987
[Serum NSE (neuron-specific enolase) levels in small cell lung cancer, with special reference to the measurement of serial serum NSE levels]S Kawachi, Z Shimabukuro, A Aoyama, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1988
[Accumulating patterns of lipiodol and therapeutic effect of combination therapy with ADMOS and CDDP two-route infusion in hepatocellular carcinoma]Y Hiraki, H Kobayashi, Y Itoh, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|August 1, 1995
[Eight cases of infection caused by the Streptococcus milleri group--significance of serum antibody titer and a comparative investigation of the backgrounds and factors of infections caused by Streptococcus milleri and Streptococcus pneumoniae]M Kimura, T Matsushima, Y Tano, et al.
Biochemical and Biophysical Research Communications|May 20, 1998
A putative tumor suppressor, TSG101, acts as a transcriptional suppressor through its coiled-coil domainM Watanabe, Y Yanagi, Y Masuhiro, et al.
Pageof 96